1α-Hydroxylase and innate immune responses to 25-hydroxyvitamin D in colonic cell lines

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 228-233

  Lagishetty, Venu ^a   Chun, Rene F ^a   Liu, Nancy Q ^a   Lisse, Thomas S ^a   Adams, John S ^a   Hewison, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1 Hydroxylase; Cathelicidin; Defensin; Epithelial cell; Macrophage; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BETA DEFENSIN 4; CALCITRIOL; CATHELICIDIN; OXYGENASE; TOLL LIKE RECEPTOR; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN; CALCIDIOL 1 MONOOXYGENASE; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; DEFB4A PROTEIN, HUMAN; LIGAND;

ANTIBACTERIAL ACTIVITY; ANTIGEN RECOGNITION; ARTICLE; CELL CULTURE; COLON MUCOSA; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE; PROTEIN EXPRESSION; VITAMIN D METABOLISM; BIOLOGICAL MODEL; CELL LINE; CELL STRAIN CACO 2; COLON; METABOLISM; POLYMERASE CHAIN REACTION;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CACO-2 CELLS; CELL LINE; COLON; HUMANS; IMMUNITY, INNATE; LIGANDS; MACROPHAGES; MODELS, BIOLOGICAL; POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTORS;

EID: 77954760418     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.02.004     Document Type: Article

References (31)

1. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., Meunier P.J. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 1997, 7(5):439-443.
2. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., Vieth R. Estimates of optimal vitamin D status. Osteoporos. Int. 2005, 16(7):713-716.
3. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357(3):266-281.
4. Hewison M. Vitamin D and innate immunity. Curr. Opin. Investig. Drugs 2008, 9(5):485-490.
5. Adams J.S., Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4(2):80-90.
6. White J.H. Vitamin D signaling, infectious diseases and regulation of innate immunity. Infect. Immun. 2008, 76(9):3837-3843.
7. Bikle D.D. Vitamin D and the immune system: role in protection against bacterial infection. Curr. Opin. Nephrol. Hypertens. 2008, 17(4):348-352.
8. Rook G.A., Steele J., Fraher L., Barker S., Karmali R., O'Riordan J., Stanford J. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986, 57(1):159-163.
9. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., Bals R., Steinmeyer A., Zugel U., Gallo R.L., Eisenberg D., Hewison M., Hollis B.W., Adams J.S., Bloom B.R., Modlin R.L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311(5768):1770-1773.
10. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19(9):1067-1077.
11. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., Tavera-Mendoza L., Lin R., Hanrahan J.W., Mader S., White J.H. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004, 173(5):2909-2912.
12. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 2007, 179(4):2060-2063.
13. Adams J.S., Ren S., Liu P.T., Chun R.F., Lagishetty V., Gombart A.F., Borregaard N., Modlin R.L., Hewison M. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J. Immunol. 2009, 182(7):4289-4295.
14. Yim S., Dhawan P., Ragunath C., Christakos S., Diamond G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J. Cyst. Fibros. 2007, 6(6):403-410.
15. Evans K.N., Nguyen L., Chan J., Innes B.A., Bulmer J.N., Kilby M.D., Hewison M. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol. Reprod. 2006, 75(6):816-822.
16. Liu N., Kaplan A.T., Low J., Nguyen L., Liu G.Y., Equils O., Hewison M. Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol. Reprod. 2009, 80(3):398-406.
17. Schauber J., Dorschner R.A., Yamasaki K., Brouha B., Gallo R.L. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 2006, 118(4):509-519.
18. Fleet J.C., Eksir F., Hance K.W., Wood R.J. Vitamin D-inducible calcium transport and gene expression in three Caco-2 cell lines. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283(3):G618-625.
19. Hewison M., Burke F., Evans K.N., Lammas D.A., Sansom D.M., Liu P., Modlin R.L., Adams J.S. Extra-renal 25-hydroxyvitamin D3-1 alpha-hydroxylase in human health and disease. J. Steroid Biochem. Mol. Biol. 2007, 103(3-5):316-321.
20. Zehnder D., Evans K.N., Kilby M.D., Bulmer J.N., Innes B.A., Stewart P.M., Hewison M. The ontogeny of 25-hydroxyvitamin D(3) 1 alpha-hydroxylase expression in human placenta and decidua. Am. J. Pathol. 2002, 161(1):105-114.
21. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J., Stewart P.M., Hewison M. Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 2001, 86(2):888-894.
22. Hewison M., Zehnder D., Chakraverty R., Adams J.S. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol. Cell. Endocrinol. 2004, 215(1-2):31-38.
23. Schauber J., Dorschner R.A., Coda A.B., Buchau A.S., Liu P.T., Kiken D., Helfrich Y.R., Kang S., Elalieh H.Z., Steinmeyer A., Zugel U., Bikle D.D., Modlin R.L., Gallo R.L. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 2007, 117(3):803-811.
24. Sadeghi K., Wessner B., Laggner U., Ploder M., Tamandl D., Friedl J., Zugel U., Steinmeyer A., Pollak A., Roth E., Boltz-Nitulescu G., Spittler A. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol. 2006, 36(2):361-370.
25. Gray T.K., Lester G.E., Lorenc R.S. Evidence for extra-renal 1 alpha-hydroxylation of 25-hydroxyvitamin D3 in pregnancy. Science 1979, 204(4399):1311-1313.
26. Weisman Y., Harell A., Edelstein S., David M., Spirer Z., Golander A. 1 alpha, 25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature 1979, 281(5729):317-319.
27. Kovacs C.S., Kronenberg H.M. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr. Rev. 1997, 18(6):832-872.
28. Bruns M.E., Bruns D.E. Vitamin D metabolism and function during pregnancy and the neonatal period. Ann. Clin. Lab. Sci. 1983, 13(6):521-530.
29. Rebut-Bonneton C., Demignon J. Effects of 1,25-dihydroxyvitamin D3 on in vitro lymphocyte reactions: arguments for a role at the maternofetal interface. Gynecol. Obstet. Invest. 1991, 32(3):134-138.
30. Rumbo M., Nempont C., Kraehenbuhl J.P., Sirard J.C. Mucosal interplay among commensal and pathogenic bacteria: lessons from flagellin and toll-like receptor 5. FEBS Lett. 2006, 580(12):2976-2984.
31. Vijay-Kumar M., Wu H., Aitken J., Kolachala V.L., Neish A.S., Sitaraman S.V., Gewirtz A.T. Activation of toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm. Bowel Dis. 2007, 13(7):856-864.